Crispr Therapeutics shares tumble after significant earnings miss
Investing.com -- Shares of Aroundtown (ETR:AT1) dropped 4.5% following the release of its financial results for the fiscal year 2024.
The company reported that its Funds From Operations (FFO) I per share was down 5% year-over-year (YoY) to €0.29, despite landing at the upper end of the guidance and exceeding Jefferies’ estimates by 4%.
The real estate company experienced a slight decrease in like-for-like (LFL) rental growth, which was reported at 2.9%, compared to 3.2% in the previous fiscal year. Looking ahead, Aroundtown expects its 2025 FFO I to be between €280 million and €310 million, translating to €0.26 to €0.28 per share, aligning closely with Jefferies’ forecasts and market consensus.
Despite the downturn in FFO I, the company’s net tangible assets per share (NTAps) saw a modest increase of 1.3% YoY to €7.45, outperforming expectations. The value decline was limited to -0.5%, showing some recovery in the second half of the year with a +1.9% increase. Furthermore, Aroundtown’s EPRA Loan-to-Value (LTV) ratio improved, decreasing by 120 basis points YoY to 59.6%.
Investors also noted the cautious stance on the dividend policy, with the company stating that the distribution per share (DPS) is "subject to market condition and AGM approval," leaving some uncertainty around shareholder returns.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.